Close Menu

Organization: PGP

Their Own Guinea Pigs

Technology Review reports some researchers are trying homemade SARS-CoV-2 vaccines on themselves.

The Personal Genome Sequencing Outcomes (PeopleSeq) Consortium surveyed more than 500 early adopters who underwent personal genome or exome sequencing.

The collaboration aims to correlate extremely high performance scores on Lumos' memory tests with genetic variations.

The PGP team used Complete Genomics' Long-Fragment Read technology to analyze the set of samples.

Veritas and the PGP share many of the same leaders, including Veritas Co-founder George Church, CSO Preston Estep, and CMO Joseph Thakuria.

Michael Smith, a Personal Genome Project Canada participant, writes at MedPage Today that his genome doesn't harbor anything to lose sleep over.

In a newsletter published last week, PGP organizers said they have now started to enroll participants for the PGP-100. Enrollment for the next phase of the project, PGP-1000, is expected to start later this year.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.